Adjuvant Therapies of Cancer

Name: Adjuvant Therapies of Cancer
Brand: Springer Nature
SKU: 9783642816871
Availability: InStock

Best Price (Coupon Required):
Buy Adjuvant Therapies of Cancer for $76.50 at @ Link.springer.com when you apply the 10% OFF coupon at checkout.
Click “Get Coupon & Buy” to copy the code and unlock the deal.

Set a price drop alert to never miss an offer.

1 Offer Price Range: $84.99 - $84.99

BEST PRICE

Single Product Purchase

$76.50

@ Link.springer.com with extra coupon

Price Comparison

Seller	Contact Seller	List Price	On Sale	Shipping	Best Promo	Final Price	Volume Discount	Financing	Availability	Seller's Page
BEST PRICE 1 Product Purchase @ Link.springer.com		$84.99	$84.99		10% OFF This deals requires coupon	$76.50		See Site	In stock	Visit Store

Product Details

Brand

Springer Nature

Manufacturer

N/A

Part Number

GTIN

9783642816871

Condition

New

Product Description

Transplantation of syngeneic (donor is a monozygous twin) or allogeneic (donor is an HLA-identical sibling) marrow provides the opportunity for aggressive antileukemic therapy without regard to marrow toxicity. Until 1975, marrow transplantation was carried out only after failure of all other therapy. Consequently, most patients were in advanced relapse. Six of 16 recipients of syngeneic marrow and 13 of 100 recipients of allogeneic marrow are still in remission after 5. 5-10 years [3, 7]. An actuarial survival curve of the first 100 patients grafted in Seattle after conditioning with cyclophos phamide (60 mg/kg on each of 2 successive days) and total body irradiation (1,000 rad) showed three periods of interest: (1) The first 4 months showed a rapid loss of patients associated with advanced illness, graft-versus-host disease, infections (in particular interstitial pneumonias), and recurrent leukemia; (2) from 4 months to 2 years, the curve showed a much slower rate of decline attributable primarily to recurrent leukemia; and (3) from 2-10 years, the curve was almost flat with a negligible loss of patients and no recurrent leukemia. This flat portion of the curve corresponded to 13% of the patients and indicates a strong probability that the majority of these survivors are cured of their disease [8]. Attempts at reducing the incidence of leukemic relapse after transplantation were made by a number of marrow transplant groups by added chemotherapy.

Available Colors

N/A

Available Sizes

N/A

Reviews

0 reviews

5 stars

4 stars

3 stars

2 stars

1 star

Questions & Answers

Similar Products

Vorlesungen ueber vergleichende Anatomie

$49.99

Recent Advances in Power Systems

$84.99

Advances in Knowledge Acquisition

$39.99

Abortion and the Law

$159.99

1950s Rocketman TV Series and Their Fans

$39.99

Scholar Zone Summer ELA and Math Grade 6 (2 Scholar)

$230.00

Computer Security - ESORICS 2008

$39.99

Assessment and Management of Environmental Risks

$169.99

Models for Optimum Decision Making

$54.99

Transparent Conductive Zinc Oxide

$219.99

Recent Advances in Gearing

$169.00

The Boston Cosmopolitans

$54.99

The Rationalists: Between Tradition and Innovation

$109.99

Enantioselective Organocatalyzed Reactions II

$129.00

Embryonenschutz im Spannungsfeld internationaler Menschenrechte, staatlicher Grundrechte und nationa

$99.99

Guide to Computational Geometry Processing

$89.99

Drahtlose Telegraphie und Telephonie

$84.99

The Book of Celtic Myths - From the Mystic Might of the Celtic Warriors to the Magic of the Fey Folk, the Storied History and Folklore of Ireland, Sco

$16.99